Would you offer definitive local therapy to a patient with ER/PR+, Her2 neg breast cancer with oligometastatic disease that responded well to CDK 4/6 inhibitor +AI, despite NRG-BR002 results?  

Young healthy patient, ER/PR positive HER2 negative right breast cancer with a synchronous single site of oligometastatic disease in the right 4th rib (near primary tumor but not clearly direct extension) and good response to 6 months of AI+CDK4i

Answer from: Medical Oncologist at Academic Institution
Medical Oncologist at Loyola University Chicago Stritch School of Medicine
See also recent updates to relevant discussion fro...
Sign in or Register to read more

Answer from: Radiation Oncologist at Community Practice
Medical Oncologist at MedStar Washington Hospital Center, MedStar Georgetown University Hospital
Dr. @Arscott, Would this be your approach for a p...
Radiation Oncologist at Compass Oncology
If enhancement properties and peritumoral edema/T2...
Sign in or Register to read more